Paina (scale from 0‐10, 0 is no pain) · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
QoL · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in adverse events compared with exercises (moderate certainty).
1 finding from 1 review
Serious adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Functional outcomes · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Global assessment of treatment success · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in global assessment of treatment success compared with placebo surgery (moderate certainty).
1 finding from 1 review
Health status and quality of life · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in adverse events compared with placebo surgery (moderate certainty).
1 finding from 1 review
Serious adverse events · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Paina (scale from 0‐10, 0 is no pain) · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Functional outcomes · people with impingement syndrome without full‐thickness rotator cuff tears
1 finding from 1 review
Global assessment of treatment success · people with impingement syndrome without full‐thickness rotator cuff tears
Subacromial decompression showed no clear difference in global assessment of treatment success compared with exercises (low certainty).
1 finding from 1 review
ACR50 response · rheumatoid arthritis of the hand
1 finding from 1 review
ACR 50% improvement · patients with rheumatoid arthritis in adults
Certolizumab pegol 200 mg sc (with or without MTX) leads to higher ACR 50% improvement compared with placebo (with or without MTX) (high certainty).
1 finding from 1 review
Clinical improvement: American College of Rheumatology 20% improvement criteria (ACR20) · patients with rheumatoid arthritis
Celecoxib probably leads to higher clinical improvement: American College of Rheumatology 20%… compared with placebo (moderate certainty).
1 finding from 1 review
Clinical improvement: American College of Rheumatology 20% improvement criteria (ACR20) · patients with rheumatoid arthritis
Celecoxib showed no clear difference in clinical improvement: American College of Rheumatology 20%… compared with traditional NSAIDs (moderate certainty).
1 finding from 1 review
Intervention not reported
ACR 50 American College of Rheumatology improvement criteria · patients with rheumatoid arthritis
The intervention probably leads to higher ACR 50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
ACR50 American College of Rheumatology 50% improvement criteria · participants with rheumatoid arthritis and with a partial response to DMARDs
The intervention probably leads to higher ACR50 American College of Rheumatology 50% improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
Outcome: ACR50 ‐ American College of Rheumatology Improvement Criteria · participants with rheumatoid arthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
ACR50 American College of Rheumatology improvement criteria · participants with rheumatoid arthritis and with partial response to MTX
The intervention probably leads to higher ACR50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review